General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Alnylam Pharma(MODEST), Ionis Pharma(MODEST), Spectrum Dynamics(MODEST), Eidos/ Bridgebio(MODEST), Pfizer(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Pfizer(SIGNIFICANT)
CONSULTING FEES/HONORARIA: Alnylam Pharma(MODEST), Ionis Pharma(MODEST), Spectrum Dynamics(MODEST), Eidos/ Bridgebio(MODEST), Pfizer(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Pfizer(SIGNIFICANT)
© 2026 American College of Cardiology Foundation. All rights reserved.
